The Predictive Role of Quantitative Electroencephalography in Evaluation of Responsiveness of Obsessive-compulsive Disorder Patients to Fluvoxamine

  • 0Department of Psychiatry, School of Behavioral Sciences, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

|

|

Summary

This summary is machine-generated.

Quantitative electroencephalography (QEEG) brainwave patterns can predict obsessive-compulsive disorder (OCD) treatment response. Medial-frontal and occipital QEEG may identify patients likely to respond to fluvoxamine therapy.

Area Of Science

  • Neuroscience
  • Psychiatry
  • Medical Technology

Background

  • Finding effective treatments for obsessive-compulsive disorder (OCD) can be challenging, often requiring lengthy trial-and-error with medications.
  • Predicting patient response to specific antidepressants like fluvoxamine is crucial for optimizing OCD treatment outcomes.

Purpose Of The Study

  • To investigate the predictive value of quantitative electroencephalography (QEEG) for fluvoxamine responsiveness in OCD patients.
  • To identify potential electrophysiological biomarkers for treatment response in OCD.

Main Methods

  • Forty medication-free, non-depressed OCD patients underwent QEEG recordings (eyes open and closed) before and after 6 weeks of fluvoxamine treatment (150-300 mg/day).
  • Relative power in different frequency bands was analyzed across all electrodes.
  • Univariate and multivariate logistic regression models were used to compare QEEG data between responders and non-responders.

Main Results

  • OCD treatment responsiveness correlated with normal relative powers in frontal electrodes (FP1, FP2, FZ, F3) and increased occipital power (O1) in the closed-eyes condition.
  • Specific QEEG patterns, including increased theta waves in frontal areas and altered alpha wave activity in occipital regions, were associated with unresponsiveness to fluvoxamine.

Conclusions

  • Quantitative electroencephalography (QEEG) patterns in medial-frontal and occipital brain regions show potential as biomarkers for predicting treatment response in OCD patients.
  • These findings suggest that QEEG could aid in personalizing fluvoxamine treatment strategies for individuals with OCD.

Related Concept Videos

Obsessive-Compulsive Disorder 01:28

210

Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...

Electroconvulsive Therapy 01:30

198

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

Antidepressant Drugs: MAOIs and Other Agents 01:23

366

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Psychosis: Goals of Pharmacotherapy 01:26

210

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation 01:30

250

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

IBS-C is primarily characterized by constipation. Individuals may experience infrequent bowel movements, difficulty passing stools, or a sensation of incomplete evacuation.
IBS-D, which involves recurrent episodes of diarrhea, is marked by an urgency to...